Company
Adaptive Biotechnologies
Powering the Age of Immune Medicine.
Also known as Adaptive Biotechnologies Corporation
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Seattle, WA, United States
- Customers
- clinicians and biopharma
- Legal name
- Adaptive Biotechnologies Corporation
- adaptivebiotech.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Adaptive Biotechnologies is harnessing this vast system of biology to unleash its power as a natural diagnostic and therapeutic tool to propel a paradigm shift in medicine.
Funding snapshot
- Total raised
- $509MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $195M2015-05-05
Funding rounds
- Round, 2015
- $195M2015-05-05, SEC form D sold, 16 investors
- Round, 2015
- $93.8M2015-01-07, SEC form D sold, 4 investors
- Round, 2015
- $95.7M2015-01-07, SEC form D sold, 61 investors
- Round, 2014
- $107M2014-04-04, SEC form D sold, 6 investors
- Round, 2013
- $5M2013-07-01, SEC form D sold, 3 investors
- Round, 2012
- $2.6M2012-06-07, SEC form D sold, 37 investors
- Round, 2011
- $5.8M2011-05-20, SEC form D sold, 63 investors
- Round, 2009
- $4M2009-12-17, SEC form D sold, 50 investors
Products
- Other
- Immune Medicine Platform
Loading relationship preview